{"generic":"Tetanus Toxoid","drugs":["TE Anatoxal Berna","Tetanus Toxoid"],"mono":{"0":{"id":"599300-s-0","title":"Generic Names","mono":"Tetanus Toxoid"},"1":{"id":"599300-s-1","title":"Dosing and Indications","sub":{"0":{"id":"599300-s-1-4","title":"Adult Dosing","mono":"<b>Tetanus; Prophylaxis:<\/b> 0.5 mL IM x 3 doses given at 0 and 4-8 weeks, and at 6-12 months after second dose; booster dose every 10 years"},"1":{"id":"599300-s-1-5","title":"Pediatric Dosing","mono":"<ul><li>Not for use in children less than 7 years of age<\/li><li><b>Tetanus; Prophylaxis:<\/b> (7 years and older) 0.5 mL IM x 3 doses given at 0 and 4-8 weeks, and at 6-12 months after second dose; booster dose every 10 years<\/li><\/ul>"},"3":{"id":"599300-s-1-7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><br\/>Tetanus; Prophylaxis<br\/><b>Non-FDA Labeled Indications<\/b><br\/>Skin test, Antigen-related<br\/>"}}},"3":{"id":"599300-s-3","title":"Contraindications\/Warnings","sub":[{"id":"599300-s-3-9","title":"Contraindications","mono":"<ul><li>febrile illness or acute infection; defer vaccination<\/li><li>history of systemic allergic or neurologic reactions to previous injection of the vaccine; only passive immunization should be given using Tetanus Immune Globulin (Human) (TIG)<\/li><li>hypersensitivity to any component of the vaccine, including thimerosal<\/li><\/ul>"},{"id":"599300-s-3-10","title":"Precautions","mono":"<ul><li>Arthus-type hypersensitivity reactions or fever following a prior dose of the vaccine<\/li><li>immunosuppression<\/li><li>latex sensitivity; the stopper to the vial contains dry natural latex rubber<\/li><li>routine booster should NOT be given more often than every 10 years<\/li><li>special care should be taken to ensure that the injection does not enter a blood vessel<\/li><li>thrombocytopenia or other coagulation disorders<\/li><\/ul>"},{"id":"599300-s-3-11","title":"Pregnancy Category","mono":"<ul><li>C (FDA)<\/li><li>A (AUS)<\/li><\/ul>"},{"id":"599300-s-3-12","title":"Breast Feeding","mono":"Micromedex: Infant risk cannot be ruled out.<br\/>"}]},"4":{"id":"599300-s-4","title":"Drug Interactions","sub":{"1":{"id":"599300-s-4-14","title":"Major","mono":"<ul>Cyclosporine (theoretical)<\/ul>"},"2":{"id":"599300-s-4-15","title":"Moderate","mono":"<ul><li>Chloramphenicol (probable)<\/li><li>Meningococcal Vaccine, Tetanus Toxoid Conjugate Quadrivalent (established)<\/li><\/ul>"}}},"5":{"id":"599300-s-5","title":"Adverse Effects","mono":"<b>Common<\/b><ul><li><b>Dermatologic:<\/b>Localized adverse reaction to administration of drug<\/li><li><b>Gastrointestinal:<\/b>Nausea<\/li><li><b>Musculoskeletal:<\/b>Arthralgia<\/li><li><b>Other:<\/b>Fever, Malaise<\/li><\/ul><b>Serious<\/b><ul><li><b>Immunologic:<\/b>Anaphylaxis (rare), Arthus type urticaria<\/li><li><b>Neurologic:<\/b>Encephalopathy, Guillain-Barr  syndrome, Seizure<\/li><li><b>Ophthalmic:<\/b>Third cranial nerve weakness<\/li><\/ul>"},"6":{"id":"599300-s-6","title":"Drug Name Info","sub":{"0":{"id":"599300-s-6-17","title":"US Trade Names","mono":"TE Anatoxal Berna<br\/>"},"2":{"id":"599300-s-6-19","title":"Class","mono":"Toxoid<br\/>"},"3":{"id":"599300-s-6-20","title":"Regulatory Status","mono":"RX<br\/>"},"4":{"id":"599300-s-6-21","title":"Generic Availability","mono":"Yes<br\/>"}}},"7":{"id":"599300-s-7","title":"Mechanism Of Action","mono":"Systemic: Following intramuscular injection of tetanus toxoid adsorbed or either intramuscular or subcutaneous injection of tetanus toxoid (fluid), an antigenic response is induced in the immunized patient, causing the formation of tetanus antibodies .<br\/>"},"9":{"id":"599300-s-9","title":"Administration","mono":"<ul><li><b>Intramuscular<\/b><br\/><ul><li>shake well prior to use; discard vial if vaccine cannot be resuspended<\/li><li>preferred injection site is in the mid-lateral aspect of the thigh or the deltoid; do not inject into the gluteal area or areas containing a major nerve trunk<\/li><li>use a separate syringe and separate site when given concurrently with tetanus immune globulin<\/li><\/ul><\/li><li><b>Subcutaneous<\/b><br\/>the booster solution may be given subQ<br\/><\/li><\/ul>"},"11":{"id":"599300-s-11","title":"How Supplied","mono":"<b>Generic<\/b><br\/>Injection Solution: 4 Lf U\/0.5 ML<br\/>"},"13":{"id":"599300-s-13","title":"Clinical Teaching","mono":"<ul><li>Patient should not have a routine booster shot more frequently than once every 10 years.<\/li><li>This drug may cause nausea, arthralgia, brachial neuritis (muscle weakness\/pain), fever, or malaise.<\/li><li> Primary immunization must be given in a series of injections. Advise patient to contact healthcare professional if a primary immunization dose is missed.<\/li><\/ul>"}}}